Clinical and ethical considerations in lung transplantation surgery in patients with post-COVID pulmonary fibrosis

• 作者: Sjaak Pouwels
• 来源期刊: 中华胸部外科电子杂志
• 年，卷（期）: 2021,（3）
• 所属期刊栏目: International Thoracic Surgery Column
• 页码范围: 153-155
• 页数: 3页
• 语种: 中文
• DOI: 10.3877/cma.j.issn.2095-8773.2021.03.03

摘要

Back in December 2019 a novel strain virus called, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) or later called Corona Virus Disease 2019 (COVID-19) rapidly spread across the globe causing major health catastrophes (1-3). To date, the rate of newly diagnosed patients is still rising in certain parts of the world, whereas in other parts life is going back to normal (e.g., same as prior to the COVID-19 pandemic) This is probably due to the rise of mutated variants of SARS-CoV-2 causing new challenges in multiple countries (4). According to the WHO, diagnosing COVID-19 needs to be done according to a specific set of criteria (5). Patients were diagnosed with a SARS-CoV-2 pneumonia [on either a conventional chest X-ray or a computed tomography (CT) scan] and one or more of the following symptoms were present; dyspnoea, increased respiratory insufficiency, decreased blood oxygen saturation and the need for supportive oxygen therapy (5). Regarding microbiological testing, real-time reverse transcriptase-polymerase chain reaction assay (RT-PCR) on throat samples can be used to identify a SARS-CoV-2 infection (6,7). In case of (multiple) negative tests and with a very clinical suspicion, faeces tests can be used to determine the diagnosis (6,7).